Clinical Trial

Ablation With Systemic Therapy vs Liver Resection With Systemic Therapy for Colorectal Liver Metastasis

Study acronym: ASRS-CRLM
Completed
View on ClinicalTrials.gov →
Summary
For patients with colorectal liver metastases (CRLM) ≤5 cm, Clinical guidelines recommend surgery, but a growing number of studies have shown that thermal ablation is as effective as surgery. However, the optimal treatment strategy remains unclear.This study aimed to compare outcomes between patients who underwent ablation with systemic therapy or liver resection with systemic therapy for CRLM less than 5 cm in diameter.
Trial Details
NCT Number NCT07559851
Lead Sponsor The First Hospital of Jilin University
Conditions Colorectal Liver Metastasis (CRLM)
Enrollment 151 participants
Start Date 2018-01-01
Primary Completion 2025-03-01 (estimated)
Study Completion 2025-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-30